Onco Filtration, Inc.

Onco Filtration, Inc. has developed a revolutionary technology known as Onco Capture™, which aims to transform cancer outcomes. The fully patented system is designed to filter unparalleled volumes of circulating tumor cells (CTCs) from whole blood, boasting a capability to filter over 1000 times (1000x) more CTCs compared to the only FDA approved technology currently available. This significant advancement in CTC capture opens up new diagnostic and therapeutic possibilities in oncology, disrupting the field of cancer technology and offering the potential to fundamentally transform patient outcomes. The company, founded in an unspecified year, presents an intriguing opportunity for venture capital investment in the cancer research and biotechnology sector. With its groundbreaking technology and potential for industry disruption, Onco Filtration, Inc. is a noteworthy player to watch in the realm of oncology innovation.